Clinical Trial Update: Falls: A Marker of Preclinical AD

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating falls as a potential marker of preclinical Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Washington University School of Medicine | Conditions: Fall, Alzheimer Disease | Status: COMPLETED